Protea Biosciences Group, Inc. (OTCBB: PRGB) is a commercial-stage molecular information company providing innovative technologies, software and services to the pharmaceutical, biotechnology, agriculture, chemical and other industries. Its proprietary technology, LAESI®, is able to detect the presence of molecules from a single analysis of samples that can include tissues, cells, fluids, agricultural specimens and other sample types. Using Protea’s proprietary ProteaPlot™ software, the location of each distinct molecule in a respective sample can be displayed, enabling direct molecular imaging. LAESI DP-1000 is an integrated system that combines LAESI and ProteaPlot. For more information, visit the company’s website at www.proteabio.com